Turnstone Biologics
Driving innate and adaptive tumor immunity to provide benefit to cancer patients underserved by current treatments.
Launch date
Employees
Market cap
$15.3m
Enterprise valuation
($45m) (Public information from Sep 2024)
Share price
$0.675 TSBX
San Francisco California (HQ)
Authorizing premium user...